Xtant Medical Holdings, Inc. (XTNT) Earnings Call Analysis
AMEX · Healthcare · Medical Devices
Earnings Reports
-
Extant Medical (XTNT) Q1 2026: Hemoblast Adds $2B TAM as Portfolio Refocus Drives Guidance Raise
May 13, 2026
-
Extant Medical (XTNT) Q4 2025: Biologics Core Set to Accelerate After $21M Portfolio Divestiture
March 31, 2026
-
XTNT Q3 2025: Licensing Revenue Drives $5.5M Boost as Biologics Expansion Targets Double-Digit Growth
November 11, 2025
-
XTNT Q2 2025: $19M Asset Sale Refocuses Portfolio, Biologics Growth Hits 20%
August 12, 2025